1. Home
  2. MBBC vs ATNM Comparison

MBBC vs ATNM Comparison

Compare MBBC & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

BUY

Current Price

$13.76

Market Cap

40.2M

Sector

Finance

ML Signal

BUY

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.28

Market Cap

36.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBBC
ATNM
Founded
1902
2000
Country
United States
United States
Employees
35
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
36.8M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
MBBC
ATNM
Price
$13.76
$1.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
12.0K
254.3K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
N/A
Revenue
N/A
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$47.11
N/A
Revenue Growth
N/A
11.11
52 Week Low
$9.94
$0.95
52 Week High
$14.64
$1.95

Technical Indicators

Market Signals
Indicator
MBBC
ATNM
Relative Strength Index (RSI) 61.62 54.72
Support Level $12.93 $1.28
Resistance Level N/A $1.38
Average True Range (ATR) 0.41 0.11
MACD 0.07 0.02
Stochastic Oscillator 99.47 46.87

Price Performance

Historical Comparison
MBBC
ATNM

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: